2020 Q1 Form 10-Q Financial Statement

#000117494720000643 Filed on May 06, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q1
Revenue $123.6M $114.0M
YoY Change 8.42% -13.05%
Cost Of Revenue $87.63M $81.44M
YoY Change 7.6% -14.54%
Gross Profit $36.01M $32.60M
YoY Change 10.47% -9.0%
Gross Profit Margin 29.12% 28.58%
Selling, General & Admin $15.85M $16.15M
YoY Change -1.85% -6.13%
% of Gross Profit 44.01% 49.53%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $7.214M $7.486M
YoY Change -3.63% -8.71%
% of Gross Profit 20.03% 22.97%
Operating Expenses $15.85M $16.15M
YoY Change -1.85% -6.68%
Operating Profit $20.16M $16.45M
YoY Change 22.56% -11.17%
Interest Expense -$25.00K -$26.00K
YoY Change -3.85%
% of Operating Profit -0.12% -0.16%
Other Income/Expense, Net $648.0K $948.0K
YoY Change -31.65% 216.0%
Pretax Income $20.81M $17.40M
YoY Change 19.6% -7.94%
Income Tax $5.473M $4.367M
% Of Pretax Income 26.3% 25.1%
Net Earnings $15.34M $13.03M
YoY Change 17.69% -8.63%
Net Earnings / Revenue 12.41% 11.43%
Basic Earnings Per Share $0.88 $0.75
Diluted Earnings Per Share $0.87 $0.74
COMMON SHARES
Basic Shares Outstanding 17.46M shares 17.46M shares
Diluted Shares Outstanding 17.72M shares 17.72M shares

Balance Sheet

Concept 2020 Q1 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $187.6M $134.9M
YoY Change 39.07% 31.35%
Cash & Equivalents $37.98M $35.39M
Short-Term Investments $149.6M $99.50M
Other Short-Term Assets $2.900M $3.100M
YoY Change -6.45% 3.33%
Inventory $18.29M $36.50M
Prepaid Expenses
Receivables $55.80M $52.20M
Other Receivables $0.00 $0.00
Total Short-Term Assets $264.6M $226.7M
YoY Change 16.72% 17.52%
LONG-TERM ASSETS
Property, Plant & Equipment $73.30M $80.70M
YoY Change -9.17% -16.89%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $24.40M $24.30M
YoY Change 0.41% 82.71%
Total Long-Term Assets $97.80M $105.0M
YoY Change -6.86% -4.89%
TOTAL ASSETS
Total Short-Term Assets $264.6M $226.7M
Total Long-Term Assets $97.80M $105.0M
Total Assets $362.4M $331.7M
YoY Change 9.26% 9.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $28.80M $27.80M
YoY Change 3.6% -1.42%
Accrued Expenses $20.70M $18.80M
YoY Change 10.11% -11.74%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $62.50M $55.60M
YoY Change 12.41% -13.13%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.100M $2.200M
YoY Change -4.55% 2100.0%
Total Long-Term Liabilities $2.100M $2.200M
YoY Change -4.55% 2100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $62.50M $55.60M
Total Long-Term Liabilities $2.100M $2.200M
Total Liabilities $64.60M $57.80M
YoY Change 11.76% -10.8%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $145.6M
YoY Change
Treasury Stock Shares
Shareholders Equity $297.8M $273.9M
YoY Change
Total Liabilities & Shareholders Equity $362.4M $331.7M
YoY Change 9.26% 9.36%

Cashflow Statement

Concept 2020 Q1 2019 Q1
OPERATING ACTIVITIES
Net Income $15.34M $13.03M
YoY Change 17.69% -8.63%
Depreciation, Depletion And Amortization $7.214M $7.486M
YoY Change -3.63% -8.71%
Cash From Operating Activities $31.07M -$10.30M
YoY Change -401.6% -122.74%
INVESTING ACTIVITIES
Capital Expenditures $4.094M $2.711M
YoY Change 51.01% -293.64%
Acquisitions
YoY Change
Other Investing Activities -$20.10M $14.80M
YoY Change -235.81%
Cash From Investing Activities -$24.18M $12.09M
YoY Change -299.99% -963.64%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$4.331M -$4.887M
YoY Change -11.38% 3.98%
NET CHANGE
Cash From Operating Activities $31.07M -$10.30M
Cash From Investing Activities -$24.18M $12.09M
Cash From Financing Activities -$4.331M -$4.887M
Net Change In Cash $2.559M -$3.098M
YoY Change -182.6% -107.9%
FREE CASH FLOW
Cash From Operating Activities $31.07M -$10.30M
Capital Expenditures $4.094M $2.711M
Free Cash Flow $26.98M -$13.01M
YoY Change -307.31% -127.87%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q1 dei Amendment Flag
AmendmentFlag
false
CY2020Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000095029
CY2020Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2020Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
348961000 USD
CY2020Q1 us-gaap Revenues
Revenues
123639000 USD
CY2019Q1 us-gaap Revenues
Revenues
114038000 USD
CY2020Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
87630000 USD
CY2019Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
81441000 USD
CY2020Q1 us-gaap Gross Profit
GrossProfit
36009000 USD
CY2019Q1 us-gaap Gross Profit
GrossProfit
32597000 USD
CY2020Q1 us-gaap Selling Expense
SellingExpense
7636000 USD
CY2019Q1 us-gaap Selling Expense
SellingExpense
8131000 USD
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8210000 USD
CY2019Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8014000 USD
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
15846000 USD
CY2019Q1 us-gaap Operating Expenses
OperatingExpenses
16145000 USD
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
20163000 USD
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
16452000 USD
CY2020Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
566000 USD
CY2019Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
679000 USD
CY2020Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-25000 USD
CY2019Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-26000 USD
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
107000 USD
CY2019Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
295000 USD
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
648000 USD
CY2019Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
948000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
20811000 USD
CY2020Q1 rgr Deferred Incom Taxes
DeferredIncomTaxes
3863000 USD
CY2019Q4 rgr Deferred Incom Taxes
DeferredIncomTaxes
5393000 USD
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
362399000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
285458000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
348961000 USD
CY2019Q4 us-gaap Treasury Stock Value
TreasuryStockValue
145590000 USD
CY2020Q1 us-gaap Treasury Stock Value
TreasuryStockValue
145590000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
297819000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
13033000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
15338000 USD
CY2019Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
6665398 shares
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
15338000 USD
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
17400000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5473000 USD
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4367000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
15338000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
13033000 USD
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.88
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.75
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.87
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.74
CY2020Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.18
CY2019Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.28
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
285458000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
1297000 USD
CY2020Q1 us-gaap Dividends Common Stock
DividendsCommonStock
3034000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1354000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
297819000 USD
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7214000 USD
CY2019Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7486000 USD
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1354000 USD
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1541000 USD
CY2020Q1 us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
1530000 USD
CY2019Q1 us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
411000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3196000 USD
CY2019Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
7187000 USD
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-10012000 USD
CY2019Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
5062000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-266000 USD
CY2019Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-4485000 USD
CY2020Q1 rgr Contract Liability To Customers
ContractLiabilityToCustomers
-1060000 USD
CY2019Q1 rgr Contract Liability To Customers
ContractLiabilityToCustomers
-3518000 USD
CY2020Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
127000 USD
CY2019Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-8157000 USD
CY2020Q1 rgr Increase Decrease In Product Liability
IncreaseDecreaseInProductLiability
-58000 USD
CY2019Q1 rgr Increase Decrease In Product Liability
IncreaseDecreaseInProductLiability
501000 USD
CY2020Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
2384000 USD
CY2019Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
4872000 USD
CY2020Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
2460000 USD
CY2019Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
7000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
31071000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10302000 USD
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4094000 USD
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2711000 USD
CY2020Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
89535000 USD
CY2019Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
44961000 USD
CY2020Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
69448000 USD
CY2019Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
59763000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-24181000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
12091000 USD
CY2020Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1297000 USD
CY2019Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
USD
CY2020Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
3034000 USD
CY2019Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
4887000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4331000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4887000 USD
CY2020Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2559000 USD
CY2019Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-3098000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
35420000 USD
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
38492000 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
37979000 USD
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
35394000 USD
CY2020Q1 us-gaap Basis Of Accounting
BasisOfAccounting
<p id="d1e3300_anchor" style="font-family: Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:6pt; margin-bottom: 0pt;"> <span style="font-weight: bold; ">NOTE 1 — BASIS OF PRESENTATION</span></p> <p style="font-family: Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:6pt; text-indent: 18pt; margin-bottom: 0pt;">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and disclosures required by accounting principles generally accepted in the United States of America for complete financial statements.</p> <p style="font-family: Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:6pt; text-indent: 18pt; margin-bottom: 0pt;">In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of normal recurring accruals, considered necessary for a fair presentation of the results of the interim periods. Operating results for the three months ended March 28, 2020 may not be indicative of the results to be expected for the full year ending December 31, 2020. These financial statements have been prepared on a basis that is substantially consistent with the accounting principles applied in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019. </p>
CY2020Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family: Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:6pt; margin-bottom: 0pt;"> <span style="border-bottom: 1pt solid;font-style: italic; ">Use of Estimates:</span></p> <p style="font-family: Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:6pt; text-indent: 18pt; margin-bottom: 0pt;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates. </p>
CY2020Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family: Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:6pt; margin-bottom: 0pt;"> <span style="border-bottom: 1pt solid;font-style: italic; ">Reclassifications:</span></p> <p style="font-family: Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:6pt; text-indent: 18pt; margin-bottom: 0pt;">Certain prior period balances have been reclassified to conform to current year presentation. </p>
CY2019Q4 us-gaap Deferred Revenue
DeferredRevenue
9623000 USD
CY2018Q4 us-gaap Deferred Revenue
DeferredRevenue
7477000 USD
CY2020Q1 rgr Revenue Deferred
RevenueDeferred
3484000 USD
CY2019Q1 rgr Revenue Deferred
RevenueDeferred
1066000 USD
CY2020Q1 rgr Deferred Revenue Recognized
DeferredRevenueRecognized
-4544000 USD
CY2019Q1 rgr Deferred Revenue Recognized
DeferredRevenueRecognized
-4584000 USD
CY2020Q1 us-gaap Deferred Revenue
DeferredRevenue
8563000 USD
CY2019Q1 us-gaap Deferred Revenue
DeferredRevenue
3959000 USD
CY2020Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
6040000 USD
CY2019Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
13131000 USD
CY2020Q1 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
62755000 USD
CY2019Q4 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
65880000 USD
CY2020Q1 us-gaap Inventory Gross
InventoryGross
68795000 USD
CY2019Q4 us-gaap Inventory Gross
InventoryGross
79011000 USD
CY2020Q1 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
47481000 USD
CY2019Q4 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
47137000 USD
CY2020Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
3025000 USD
CY2019Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
3573000 USD
CY2020Q1 us-gaap Inventory Net
InventoryNet
18289000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
28301000 USD
CY2020Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2065000 USD
CY2020Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
2514000 USD
CY2020Q1 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
430000 USD
CY2020Q1 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
559000 USD
CY2020Q1 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
244000 USD
CY2020Q1 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
213000 USD
CY2020Q1 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
215000 USD
CY2020Q1 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
1600000 USD
CY2020Q1 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
3261000 USD
CY2020Q1 rgr Present Value Discount Of Operating Lease
PresentValueDiscountOfOperatingLease
-747000 USD
CY2020Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
2514000 USD
CY2020Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P11Y10M20D
CY2020Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
40000000 USD
CY2020Q1 us-gaap Line Of Credit Facility Interest Rate Description
LineOfCreditFacilityInterestRateDescription
LIBOR
CY2020Q1 rgr Line Of Credit Facility Reference Rate Percentage
LineOfCreditFacilityReferenceRatePercentage
0.01016 pure
CY2020Q1 us-gaap Debt Instrument Basis Spread On Variable Rate1
DebtInstrumentBasisSpreadOnVariableRate1
0.0150 pure
CY2020Q1 us-gaap Line Of Credit Facility Unused Capacity Commitment Fee Percentage
LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
0.0025 pure
CY2020Q1 rgr Defined Benefit Plan Contributions By Employer For Remainder Of Fiscal Year
DefinedBenefitPlanContributionsByEmployerForRemainderOfFiscalYear
4000000.0 USD
CY2020Q1 us-gaap Defined Contribution Plan Administrative Expenses
DefinedContributionPlanAdministrativeExpenses
900000 USD
CY2019Q1 us-gaap Defined Contribution Plan Administrative Expenses
DefinedContributionPlanAdministrativeExpenses
1200000 USD
CY2020Q1 rgr Estimated Cost For Defined Benefit Plans
EstimatedCostForDefinedBenefitPlans
2700000 USD
CY2020Q1 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
1500000 USD
CY2019Q1 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
1700000 USD
CY2020Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.263 pure
CY2019Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.251 pure
CY2020Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1600000 USD
CY2019Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
4000000.0 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
15338000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
13033000 USD
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17461524 shares
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17458020 shares
CY2020Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
257894 shares
CY2019Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
263718 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17719418 shares
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17721738 shares
CY2020Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 pure
CY2020Q1 us-gaap Revenues
Revenues
123639000 USD
CY2019Q1 us-gaap Revenues
Revenues
114038000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
20811000 USD
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
17400000 USD
CY2020Q1 us-gaap Assets
Assets
362399000 USD
CY2019Q4 us-gaap Assets
Assets
348961000 USD
CY2020Q1 rgr Threshold Limit Of Losses Per Transaction For Taking Insurance Coverage On Annual Basis
ThresholdLimitOfLossesPerTransactionForTakingInsuranceCoverageOnAnnualBasis
5000000 USD
CY2020Q1 rgr Threshold Limit Of Aggregate Loss For Insurance Coverage On Annual Basis Excluding New Claims From Governments Or Municipalities
ThresholdLimitOfAggregateLossForInsuranceCoverageOnAnnualBasisExcludingNewClaimsFromGovernmentsOrMunicipalities
10000000 USD
CY2019 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
100000 USD
CY2018 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
100000 USD

Files In Submission

Name View Source Status
0001174947-20-000643-index-headers.html Edgar Link pending
0001174947-20-000643-index.html Edgar Link pending
0001174947-20-000643.txt Edgar Link pending
0001174947-20-000643-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rgr-20200328.xsd Edgar Link pending
rgr-20200328_cal.xml Edgar Link unprocessable
rgr-20200328_def.xml Edgar Link unprocessable
rgr-20200328_lab.xml Edgar Link unprocessable
rgr-20200328_pre.xml Edgar Link unprocessable
rgr10qex31-1.htm Edgar Link pending
rgr10qex31-2.htm Edgar Link pending
rgr10qex32-1.htm Edgar Link pending
rgr10qex32-2.htm Edgar Link pending
rgr10qq1-2020.htm Edgar Link pending
rgr10qq1-2020_htm.xml Edgar Link completed
Show.js Edgar Link pending